Llwytho...
Generalization and representativeness of phase III immune checkpoint blockade trials in non‐small cell lung cancer
BACKGROUND: Strict eligibility criteria for patient enrollment in phase III trials raise questions regarding generalization to ineligible patients. We evaluated whether pivotal phase III trials of immune checkpoint blockades (ICBs) represent the overall population of non‐small cell lung cancer (NSCL...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Thorac Cancer |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley & Sons Australia, Ltd
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6456815/ https://ncbi.nlm.nih.gov/pubmed/29682899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12641 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|